These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12584036)
1. Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone. Gutteridge DH; Retallack RW; Ward LC; Price RI; Stewart GO; Stuckey BG; Prince RL; Kent GN; Bhagat CI; Thompson RI; Nicholson GC Bone; 2003 Jan; 32(1):56-61. PubMed ID: 12584036 [TBL] [Abstract][Full Text] [Related]
2. Rapid, divergent changes in spinal and forearm bone density following short-term intravenous treatment of Paget's disease with pamidronate disodium. Price RI; Gutteridge DH; Stuckey BG; Kent GN; Retallack RW; Prince RL; Bhagat CI; Johnston CA; Nicholson GC; Stewart GO J Bone Miner Res; 1993 Feb; 8(2):209-17. PubMed ID: 8442439 [TBL] [Abstract][Full Text] [Related]
3. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium. Stewart GO; Gutteridge DH; Price RI; Ward L; Retallack RW; Prince RL; Stuckey BG; Kent GN; Bhagat CI; Dhaliwal SS Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784 [TBL] [Abstract][Full Text] [Related]
4. Measurement of bone mineral density by dual X-ray absorptiometry in Paget's disease before and after pamidronate treatment. Laroche M; Delpech B; Bernard J; Constantin A; Mazières B Calcif Tissue Int; 1999 Sep; 65(3):188-91. PubMed ID: 10441648 [TBL] [Abstract][Full Text] [Related]
5. Clinical, biochemical, hematologic, and radiographic responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Gutteridge DH; Retallack RW; Ward LC; Stuckey BG; Stewart GO; Prince RL; Kent GN; Bhagat CI; Price RI; Thompson RI; Nicholson GC Bone; 1996 Oct; 19(4):387-94. PubMed ID: 8894145 [TBL] [Abstract][Full Text] [Related]
6. Changes in bone mineral density in patients with Paget's disease treated with risedronate. Patel S; Pearson D; Bhallah A; Maslanka W; White DA; Hosking DJ Ann Rheum Dis; 1997 Jul; 56(7):405-9. PubMed ID: 9486001 [TBL] [Abstract][Full Text] [Related]
7. Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study. Krieg MA; Seydoux C; Sandini L; Goy JJ; Berguer DG; Thiébaud D; Burckhardt P Osteoporos Int; 2001; 12(2):112-6. PubMed ID: 11303710 [TBL] [Abstract][Full Text] [Related]
8. Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation. Dodidou P; Bruckner T; Hosch S; Haass M; Klar E; Sauer P; Ziegler R; Leidig-Bruckner G Osteoporos Int; 2003 Jan; 14(1):82-9. PubMed ID: 12577189 [TBL] [Abstract][Full Text] [Related]
9. Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate. Vasireddy S; Talwalkar A; Miller H; Mehan R; Swinson DR Clin Rheumatol; 2003 Dec; 22(6):376-80. PubMed ID: 14677009 [TBL] [Abstract][Full Text] [Related]
10. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy. Wimalawansa SJ; Gunasekera RD Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351 [TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission. Stuckey BG; Lim EM; Kent GN; Ward LC; Gutteridge DH J Bone Miner Res; 2001 Sep; 16(9):1719-23. PubMed ID: 11547843 [TBL] [Abstract][Full Text] [Related]
12. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis. Thiébaud D; Burckhardt P; Kriegbaum H; Huss H; Mulder H; Juttmann JR; Schöter KH Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122 [TBL] [Abstract][Full Text] [Related]
13. [Histomorphometric study of nonpagetic bone in Paget patients. Results before and after diphosphonates]. Coindre JM; Edouard CM; Arlot ME; Meunier PJ Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):103-9. PubMed ID: 7063793 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Paget's disease of bone with single dose intravenous pamidronate. Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628 [TBL] [Abstract][Full Text] [Related]
15. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone. Ryan PJ; Gibson T; Fogelman I J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830 [TBL] [Abstract][Full Text] [Related]
16. Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause. Thiébaud D; Burckhardt P; Melchior J; Eckert P; Jacquet AF; Schnyder P; Gobelet C Osteoporos Int; 1994 Mar; 4(2):76-83. PubMed ID: 8003844 [TBL] [Abstract][Full Text] [Related]
17. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone. Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473 [TBL] [Abstract][Full Text] [Related]
18. Ultrasound velocity and dual-energy X-ray absorptiometry in normal and pagetic bone. Pande KC; Bernard J; McCloskey EV; de Takats D; Kanis JA Bone; 2000 May; 26(5):525-8. PubMed ID: 10773594 [TBL] [Abstract][Full Text] [Related]
19. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate. Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031 [TBL] [Abstract][Full Text] [Related]
20. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Fromm GA; Vega E; Plantalech L; Galich AM; Mautalen CA Osteoporos Int; 1991 Jun; 1(3):129-33. PubMed ID: 1790400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]